Discovery and Research

Advancing drug discovery with organoid data analysis using QIAGEN Ingenuity Pathway Analysis and Omicsoft

420 views
December 14, 2021
Three-dimensional (3D) cell culture structures like spheroids and organoids can be used to better understand complex diseases and deliver insights into potential theraputic opportunities. They are also complementary to two-dimensional (2D) cell cultures and in vivo models. These model systems offer scientists a detailed view of organ development, new insights on human development and disease, improving drug discovery and creating new approaches to precision medicine endeavors. Accordingly, this training will focus on using QIAGEN Ingenuity Pathway Analysis (IPA) and Omicsoft to study gene signatures in ‘omics data related to disease mechanisms and exploring drug action using organoid models.

During this 90-minute training, using Ingenuity Pathway Analysis/Omicsoft in combination with organoid data, attendees will learn how to:
• Quickly identify and study impacted pathways
• Establish biological mechanism underlying the diseases and drug treatments
• Easily compare datasets of interest with other user or public data pertaining to 2D cultures, 3D organoid cultures, in-vivo models or clinical studies to generate a strong hypothesis
• Export high quality graphical and tabular results

Speaker: Sumana Chintalapudi, Field Application Scientist, QIAGEN Digital Insights

Related videos

Discovery and Research

Exploring IPA’s Analysis Match: An Overview

5,436 views November 07, 2018

Learn about the new Analysis Match features and discover a new way to explore...

QIAGEN CLC Genomics

QIAGEN CLC Genomics Workbench 20 – scalable desktop software for NGS data analysis

4,941 views January 28, 2020

In this webinar, Leif Schauser, Ph.D., Director Product Management Genome...

Discovery and Research

CLC Genomics Workbench 12

2,805 views November 27, 2018

Introducing CLC Genomics Workbench 12 – an exciting new release that’s making...